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Influenza pandemics resemble major natural disasters. According to the list that has been 
published by World Health Organization (WHO), the number of total cases of avian influenza is 
387cases and 245 of those cases had cause deaths. The number of total cases and deaths shows 
that there was an increased pandemic threat. Justifiably, this had caused the world-wide public 
concern and it also explains the need for vaccine production for this Avian Influenza. The main 
antigenic determinants of influenza A and B viruses are the haemagglutinin (HA) and 
neuraminidase (NA) transmembrane glycoproteins. The activities ofHA and NA are functionally 
linked and make them the most potential candidates for the avian influenza disease vaccine in 
human. In this study, highly immunogenic/ hydrophilic regions ofNAIHA gene was constructed 
using assembly PCR. The synthetic gene was constructed using assembly PCR and cloned into 
pCR®2.1-TOPO®vector. The recombinant plasmid isolated from the colony was send for 
sequencing and alignment result shows that there were three errors in the synthetic gene being 
constructed. PCR-based site directed mutagenesis technique must be performed to repair those 
errors. Although the synthetic gene was not developed as originally planned, this study has 
generated data that would be useful towards achieving that goal in the future. 
IX 
ABSTRAK 
Pandemik selsema merupakan salah satu bencana semula jadi yang penting (major). 
Menurut senarai yang telah dikeluarkan oleh Pertubuhan Kesihatan Sedunia (WHO), jumlah kes 
yang berkaitan dengan avian influenza (selsema burung) ialah 387 dan 245 daripadanya telah 
menyebabkan kematian. Bilangan kes dan angka kematian yang berkaitan dengan selsema 
burung menunjukkan bahawa terdapa1nya peningkatan ancaman pandemik. Sebenamya 
peningkatan kes dan angka kematian ini telah membawa kepada kebimbangan masyarakat 
seluruh dunia dan ini juga telah menjelaskan tentang keperluan untuk menghasilkan vaksin bagi 
selsema burung. Penentu antigenic yang utama bagi virus influenza A dan B adalah glikoprotein 
transmembran, haemagglutinin (HA) dan neuraminidase (NA). Fungsi HA dan NA berkaitan 
antara satu sama lain dan ini menjadikan mereka calon yang berpotensasi untuk dijadikan vaksin 
terhadap penyakit selsema burung. Dalam kajian ini, bahagian NA dan HA yang mempunyai 
kekebalan yang tinggi dan suka air 'hydrophilic' telah cuba untuk dihasilkan dengan 
menggunakan PCR himpunan (Assembly PCR). Gene sintetik yang telah dihasilkan dengan 
bantuan PCR himpunan telah diklonkan ke dalam vector pCR®2.1-TOPO®. Plasmid 
rekombinan yang telah berjaya diekstrak daripada koloni telah dihantar untuk penjujukan 
(Sequencing). Hasil kajian ini menunjukkan bahawa terdapat tiga kesilapan dalam gen yang telah 
dihasilkan. Jadi teknik 'PCR-based site directed mutagenesis' perlu dijalankan untuk 
memperbaiki kesilapan tersebut. Walaupun gen sintetik tidak dihasilkan seperti yang 
dirancangkan, tetapi kajian ini telah memberi kita maklumat yang akan membantu mencapai 




Thirty years ago, infectious diseases were seemingly on the decline. Tuberculosis was 
defeated, small pox was about to be eradicated, sexually transmissible diseases could easily be 
treated, and other scourges of mankind, such as malaria, were expected to disappear one day. 
Some experts hilariously announced that we would soon be able to close the book of infectious 
diseases once and for all. But, that was before the beginning of the Acquired Immune Deficiency 
Syndrome (AIDS) pandemic in 1981, and before the discovery of the hepatitis C virus, as well as 
many other viruses capable of causing severe disease in humans (Kamps eta/., 2006). 
In a world with an increasing potential for the rapid spread of pathogens due to 
overcrowded cities and high mobility, the role of efficient infectious disease task forces can 
therefore not be overestimated. In the wake of Human Immunodeficiency Virus {HIV), hepatitis 
C, drug-resistant tuberculosis, and Severe Acute Respiratory Syndrome (SARS), another 
devastating influenza pandemic may be the next global health threat that six and a half billion 
people will have to face. 
An avian influenza strain, H5N1, has recently caused multiple outbreaks in poultry on 
three continents and has infected nearly 385 persons, killing more than half of them (World 
Health Organization, 2008 ). 
1.1 Influenza 
Influenza which is commonly known as flu is a contagious respiratory illness caused by 
influenza viruses. It can cause mild to severe illness, and at times can lead to death. Some 
people, such as older people, young children, and people with certain health conditions, are at 
high risk for serious flu complications (Centers for Disease Control and Prevention, 2007a). 
1.2 Avian Influenza 
Avian influenza which is commonly known as 'bird flu', is an infection caused by avian 
(bird) influenza (flu) viruses. These influenza viruses occur naturally among birds. Wild birds 
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worldwide carry the viruses in their intestines, but usually do not get sick from them. However, 
avian influenza is very contagious among birds and can make some domesticated birds, 
including chickens, ducks, and turkeys, very sick and kill them. 
Infected birds shed influenza virus in their saliva, nasal secretions, and feces. Susceptible 
birds become infected when they have contact with contaminated secretions or excretions or with 
surfaces that are contaminated with secretions or excretions from infected birds. Domesticated 
birds may become infected with avian influenza virus through direct contact with infected 
waterfowl or other infected poultry, or through contact with surfaces such as dirt or cages or 
materials such as water or feed that have been contaminated with the virus (Kamps eta/., 2006, 
Skeik and Jabr, 2008). 
Infection with avian influenza viruses in domestic poultry causes two main forms of 
disease that are distinguished by low and high extremes of virulence. The "low pathogenic'' form 
may go undetected and usually causes only mild symptoms such as ruffied feathers and a drop in 
egg production. However, the highly pathogenic form spreads more rapidly through flocks of 
poultry. This form may cause disease that affects multiple internal organs and has a mortality 
rate that can reach 90-100% often within 48 hours (Centers for Disease Control and Prevention, 
2007b). 
Usually, "avian influenza virus" refers to influenza A viruses found chiefly in birds, but 
infections with these viruses can occur in humans. The risk from avian influenza is generally low 
to most people, because the viruses do not usually infect humans. However, confirmed cases of 
human infection from several subtypes of avian influenza infection have been reported since 
1997. Most cases of avian influenza infection in humans have resulted from contact with infected 
poultry (for example, domesticated chicken, ducks, and turkeys) or surfaces contaminated with 
secretion/excretions from infected birds. The spread of avian influenza viruses from one ill 
person to another has been reported very rarely, and has been limited, inefficient and unsustained 
(Centers for Disease Control and Prevention, 2007b, Kamps eta/., 2006). 
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1.3 Avian Influenza Virus 
Usually, "avian influenza virus" refers to influenza type A viruses. There are many 
different subtypes of type A influenza v iruses. These subtypes differ because of changes in 
certain proteins on the surface of the influenza A virus (hemagglutinin [HA] and neuraminidase 
[NA] proteins). There are 16 known HA subtypes and 9 known NA subtypes of influenza A 
viruses. Many different combinations of HA and NA proteins are possib le. Each combination 
represents a different subtype. All known subtypes of influenza A v iruses can be found in birds. 
Figure 1.1 shows the structural diagram of the typical influenza virus (Kamps el a/. , 2006). 
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Figure 1.1 Structu.-al Diagram of the Influenza Virus 
HSN 1, a lso known as A (H5N1) or simply H5Nl , is a subtype of the influenza A virus. A 
bird-adapted strain of H5N1 , called HP AI A (H5N1) for "highly pathogenic avian influenza 
virus of type A of subtype H5N1 ", is the causative agent of H5N1 flu, commonly known as 
"avian influenza" or "bird flu" . H5N1 is a subtype of the species influenza A virus of the 
influenza virus A genus of the Orthomyxoviridae family. Like a ll other influenza A subtypes, the 
H5N1 subtype is an RNA virus. 
Influenza viruses are usually transmitted via air droplets, and subsequently contaminate 
the mucosa of the respiratory tract. They are able to penetrate the mucin layer of the outer 
surface of the respiratory tract, entering respiratory epithelial cells, as well as other cell types. 
Replication is very quick: after only 6 hours the first influenza viruses are shed from infected 
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cells.H5Nl is easily transmissible between birds facilitating a potential global spread of H5Nl. 
Influenza viruses have a relatively high mutation rate that is characteristic of RNA viruses. The 
segmentation of its genome facilitates genetic recombination by segment reassortment in hosts 
infected with two different influenza viruses at the same time. A previously uncontagious strain 
may then be able to pass between humans, one of several possible paths to a pandemic. 
The ability of various influenza strains to show species-selectivity is largely due to 
variation in the hemagglutinin genes. Genetic mutations in the hemagglutinin gene that cause 
single amino acid substitutions can significantly alter the ability of viral hemagglutinin proteins 
to bind to receptors on the surface of host cells. Such mutations in avian H5Nl viruses can 
change virus strains from being inefficient at infecting human cells to being as efficient in 
causing human infections as more common human influenza virus types. This doesn't mean that 
one amino acid substitution can cause a pandemic, but it does mean that one amino acid 
substitution can cause an avian flu virus that is not pathogenic in humans to become pathogenic 
in humans (Centers for Disease Control and Prevention, 2007b, Kamps eta/., 2006, Skeik and 
Jabr, 2008). 
The main antigenic determinants of influenza A and B viruses are the haemagglutinin and 
the neuraminidase transmembrane glycoproteins, capable of eliciting subtype-specific and 
immune responses which are fully protective within, but only partially protective across, 
different subtypes. On the basis of the antigenicity of these glycoproteins, influenza A viruses 
currently cluster into sixteen H (HI - Hl6) and nine N (Nl - N9) subtypes. These clusters are 
substantiated when phylogenetically analyzing the nucleotide and deduced amino acid sequences 
of the HA and NA genes, respectively. The HA and NA RNA strands specify the structure of 
proteins that are most medically relevant as targets for antiviral drugs and antibodies. HA and 
NA are also used as the basis for the naming of the different subtypes of influenza A viruses. 
This is where the Hand N come from in H5Nl (Fouchier eta/., 2005, Kamps eta/., 2006). 
1.4 Structure of Influenza Virus 
Influenza viruses are enveloped single-stranded RNA vtruses with a pleomorphic 
appearance, and an average diameter of 120 nm. Projections of haemagglutinin and 
neuraminidase cover the surface of the particle. The influenza A virus genomes consist of 8 
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separate segments covered by the nucleocapsid protein. Together these build the 
ribonucleoprotein (RNP), and each segment codes for a functionally important protein: 
1. Polymerase B2 protein (PB2) 
n. Polymerase B 1 protein (PB 1) 
111. Polymerase A protein (PA) 
tv. Haemagglutinin (HA or H) 
v. Nucleocapsid protein (NP) 
vt. Neuraminidase (NA or N) 
vn. Matrix protein (M): Ml constructs the matrix; and in influenza A viruses only, M2 
acts as an ion channel pump to lower or maintain the pH of the endosome 
vut. Non-structural protein (NS); the function ofNS2 is hypothetical 
The active RNA-RNA polymerase, which is responsible for replication and transcription, 
is formed from PB2, PB 1 and PA. It has an endonuclease activity and is linked to the RNP. The 
NS 1 and NS2 proteins have a regulatory function to promote the synthesis of viral components 
in the infected cell. The envelope of the virus is a lipid bilayer membrane which originates from 
the virus-producing cell and which contains prominent projections formed by HA and NA, as 
well as the M2 protein. The lipid layer covers the matrix formed by the M1 protein (Kamps et 
a/., 2006, Wagner eta/., 2000) 
1.5 Haemagglutinin 
The haemagglutinin, a glycosylated and acylated protein consisting of 562 to 566 amino 
acids is incorporated in the viral envelope. The globular head of its membrane distal, knob-like 
external domain is associated with binding to cellular receptors composed of oligosaccharides 
which terminally carry derivates of neuraminic acid (Watowich eta/., 1994). HA contains either 
2 of 3 glycosylation sites, with a molecular weight of approximately 76,000. It spans the lipid 
membrane so that the major part, which contains at least 5 antigenic domains, is presented at the 
outer surface. 
HA serves as a receptor by binding to sialic acid (N-acetylneuraminicacid) and induces 
penetration of the interior of the virus particle by membrane fusion. Haemagglutinin is the main 
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influenza virus antigen; the antigenic sites being A, B (carrying the receptor binding site), C, D, 
and E. The antigenic sites are presented at the head of the molecule, while the feet are embedded 
in the lipid layer. The body of the HA molecule contains the stalk region and the fusiogenic 
domain which is needed for membrane fusion when the virus infects a new cell. At low pH, the 
fusion peptide is turned to an interior position. The HA forms trimers and several trimers form a 
fusion pore (Kamps eta/., 2006, Kuroda eta/., 1986). 
Prominent mutations in the antigenic sites reduce or inhibit the binding of neutralizing 
antibodies, thereby allowing a new subtype to spread within a non-immune population. This 
phenomenon is called antigenic drift. The mutations that cause the antigenic drift are the 
molecular explanation for the seasonal influenza epidemics during winter time in temperate 
climatic zones. The immune response to the HA antigenic sites is followed by the production of 
neutralising antibody, which is the basis for resolving infection in an individual, and is 
sometimes part of the cross immunity found in elderly individuals when a new pandemic virus 
strain occurs. 
Antigenic shift also termed genome reassortment or just reassortment arises when the HA 
is exchanged in a virus, for example HI replaced by H5 resulting in the formation of a mosaic 
virus. This may happen when a cell is infected by 2 different influenza viruses and their genome 
segments are exchanged during replication. This phenomenon of genome reassortment is 
frequently seen in water birds, especially ducks. Although the birds are seldom symptomatic 
after infection, the virus is shed in their faeces for several months (Kamps eta/., 2006, Wagner et 
a/., 2000). 
1.6 Neuraminidase 
Neuraminidase (NA) is a type II glycoprotein which is also found as projections on the 
surface of the virus contains an N-proximal anchor and a C-terminal ectodomain. NA is 
anchored in the viral envelope as a mushroom-shaped homotetramer with type II membrane 
topology. It forms a tetrameric structure with an average molecular weight of 220,000. Each 
subunit of the NA homotetramer consists of a cytoplasmic tail, a transmembrane domain, a stalk 
and a head region. The crystal structure of the NA head, which contains the enzyme active site, 
has been extensively studied and used in rational drug design NA acts as a receptor-destroying 
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enzyme by catalyzing the removal of sialic acids from viral and cellular components. NA activity 
has therefore been shown to promote the release of progeny viruses from host cells and to 
prevent virion aggregation. The activity of viral NA is required to prevent self-aggregation of 
progeny virions and to promote release from the cellular membrane. Antibodies to NA are also 
important in protecting hosts. The recently developed NA inhibitors zanamivir and oseltamivir 
have demonstrated therapeutic benefit in clinical trails (Gubareva eta/., 2002, Horimoto and 
Kawaoka, 2001, Kamps eta/., 2006, Wagner eta/., 2000). 
1.7 Pathogenicity of Avian Influenza Viruses 
Attachment to cell surface proteins of influenza A virions is achieved through mature 
trimerised viral HA glycoproteins. Attachment is stratified by recognition of distinct terminal 
sialic acid species (N-acetyl- or N-glycolylneuraminic acid), the type of glycosidic linkage to 
penultimate galactose ( a.2-3 or a.2-6) and the composition of further inner fragments of 
sialyloligosaccharides present at the cell surface. A variety of different sialyloligosaccharides are 
expressed with restriction to tissue and species origin in the different hosts of influenza viruses. 
Adaptation in both the viral HA and the NA glycoprotein to the specific receptor types of a 
certain host species is a prerequisite for efficient replication. 
This implies a re-shaping of the receptor binding units of the HA protein following 
interspecies transmission. Avian influenza viruses generally show the highest affinities for a.2-3 
linked sialic acid as this is the dominating receptor type in epithelial tissues of endodermic origin 
(gut, lung) in those birds that are targeted by these viruses. Human-adapted influenza viruses, in 
contrast, primarily access 2-6 linked residues which predominate on non-ciliated epithelial cells 
of the human airway. These receptor predilections define part of a species barrier preventing 
hassle-free transmission of avian viruses to humans. Yet recently, it has been shown that there is 
a population of ciliated epithelial cells in the human trachea which also carry avian receptor-like 
glycoconjugates at lower densities and also chicken cells carry human-type sialyl receptors at 
low concentrations. This might explain why humans are not entirely refractory towards infection 
with certain avian strains. (Ito eta/., 2001, Kamps eta/., 2006, Suzuki, 2005). 
Once successfully attached to a suitable receptor, the virion is internalised into an 
endosomal compartment by clathrin-dependent and -independent mechanisms. The virus escapes 
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degradation in this compartment by fusing viral and endolysomal membranes: mediated by 
proton transport through the viral matrix-2 (M2) tunnel protein at pH values in the endosome of 
around 5, a cascade of steric rearrangements in the matrix-1 (Ml) proteins and the homotrimeric 
HA glycoprotein complex commence. As a result, a highly lipophilic, fusogenic domain of each 
HA monomere is exposed which inserts itself into the endolysosomal membrane, thereby 
initiating fusion of viral and lysosomal membranes. 
In turn, the eight viral genomic RNA segments, enclosed in a protective layer of 
nucleocapsid (N) proteins (ribonucleoprotein complex, RNP) are released into the cytoplasm. 
Here they are transported to the nucleus for transcription of viral mRNAs and replication of 
genomic RNA in a complex process which is delicately regulated by viral and cellular factors. 
The RNA-dependent RNA polymerase is formed by a complex of the viral PB 1, PB2 and PA 
proteins, and requires encapsidated RNA (RNPs) for this task. Upon translation of viral proteins 
and assembly of nucleocapsids harbouring replicated genomic RNA, progeny virions bud from 
the cellular membrane into which the viral glycoproteins have previously been inserted. 
Arrangements between helical nucleocapsids and viral envelope proteins are mediated by the 
viral matrix-1 (M1) protein which forms a shell-like structure just beneath the viral envelope. 
Viral reproduction in fully permissive cells is a fast (less than ten hours) and efficient process, 
provided an optimal gene constellation is present (Cox eta/., 1997, Ito eta/., 2001, Kamps eta/., 
2006, Suzuki, 2005). 
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Figure 1.2: Replication cycle of influenza A virus (Adapted f•·om Cox & Kawaol<a 1997). 
Figure 1.2 shows the replication cycle of influenza A virus. The rep lication cycle consists 
of binding and entry of the virus, fusion with endosomal membrane and release of viral RNA, 
replication within the nucleus, synthesis of structural and envelope proteins, budding and release 
of virions capable of infecting neighboring epithelial cells (Cox eta/. , 1997). 
1.8 Complications ofHSNl Influenza 
Initial symptoms of H5N1 influenza may include fever (typically > 38°C), headache, 
malaise, myalgia, sore throat, cough, and rhinitis (although upper respiratory symptoms may be 
absent), gastrointestinal manifestations and conjunctivitis. All these symptoms are non-specific 
and may also be associated with the currently circulating human influenza virus subtypes, H1 Nl 
and H3N2. In two reports, diarrhea was a prominent feature along with shortness of breath. 
Watery diarrhea may be present well before pulmonary symptoms develop. Another report 
describes a four-year-old boy with severe diarrhea, followed by seizures, coma, and death, 
suggesting the clinical diagnosis of encephalitis. Avian influenza H5N 1 was later detected m 
cerebrospinal fluid, faecal , throat, and serum specimens (Hien eta/. , 2004). 
Laboratory findings of patients with severe avian influenza H5N1 include leucopenia, 
lymphopenia, impaired liver function with elevated liver enzymes, prolonged clotting times, and 
renal impairment The lymphocyte count appears to be the most valuable parameter for 
identification of patients who are at risk of progression to severe illness. As of December 2005, 
about half of the patients diagnosed with clinical avian H5N1 influenza infection have died. 
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Most of these patients had severe disease on admission to hospital. In patients with respiratory 
failure and fatal outcome, dyspnoea developed after a median of 5 days (range 1.16) in one 
series. Abnormal chest radiographs include interstitial infiltration, patchy lobar infiltrates in a 
variety of patterns (single lobe, multiple lobes, unilateral or bilateral distributions). The 
radiographic pattern progresses to a diffuse bilateral ground-glass appearance, with clinical 
features compatible with Acute Respiratory Disease Syndrome (ARDS). In the report from 
Vietnam, major x-ray abnormalities include extensive bilateral infiltration, lobar collapse, focal 
consolidation, and air bronchograms. All patients had dramatic worsening of findings on chest 
radiography during hospitalization. The median time from onset of fever to ARDS was 6 days 
(range 4.13) in one series. Pneumothorax may develop in patients during mechanical ventilation. 
Pleural effusions are uncommon. (Webster eta/., 2006) 
There is conflicting information as to the risk factors associated with severe disease and 
fatal outcome. In the 1997 outbreak in Hong Kong, the factors associated with severe disease 
included older age, delay in hospitalization, lower respiratory tract involvement, and a low total 
peripheral white blood cell count or lymphopenia on admission In this report_ patients aged 
below 6 years usually had a self-limiting acute respiratory disease with fever, rhinorrhoea, and 
sore throat. In contrast, recent avian H5N1 infections have caused high rates of death among 
infants and young children. The numbers reported are too small to understand whether local 
factors such as time between onset of symptoms and admission to hospital or viral virulence 
factors are responsible for these differences. As H5N1 strains have evolved over the past 10 
years, clinical features of avian influenza infection in humans may well have different 
characteristics over time. The progression of severe H5N1 infection seems to be different from 
that of severe diseases observed during earlier influenza pandemics. None of the patients with 
severe disease reported from Hong Kong and Vietnam had evidence of secondary bacterial 
pneumonia, suggesting that the fatal outcome was due to an overwhelming primary viral 
pneumonia. This feature is reminiscent of the 1918 pandemic and may pathogenetically be due to 
a "cytokine storm" (Kamps eta/., 2006, Webster eta/., 2006). 
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1.9 Treatment 
Most patients with uncomplicated human influenza, especially adolescents and young 
adults, can be treated symptomatically and need no specific intervention. In the elderly, however, 
treatment with antiviral drugs is a good option. These drugs should further be considered for 
high-risk individuals, especially patients with underlying medical conditions, as well as in a 
number of special situations. 
Neuraminidase inhibitors are effective against all variants that have caused disease in 
humans, including the virus of the 1918 pandemic. In human H5N1 influenza, treatment with an 
oral neuraminidase inhibitor, oseltamivir, seems to be effective in some cases, but may fail in 
others. Recently, resistant strains have been reported. In addition, the dosage and duration of 
treatment appear to be different in severe H5N1 cases. In the case of a future pandemic, antiviral 
drugs may play an important role in the early phase, when vaccines against the new strain are not 
yet available or as long as the available vaccine is in short supply (de Jong eta/., 2005, Kamps et 
a/., 2006, Tumpey et al., 2005). 
1.10 Current H5Nl Situation 
The Avian Influenza which is caused by H5N1 is not expected to diminish significantly 
in the short term. It is already becoming endemic in certain areas. Overall mortality in reported 
H5NI cases is approximately 60%. Influenza pandemics resemble major natural disasters. 
Human cases, first documented in 1997 coincided with outbreaks of highly pathogenic H5N1 
avian influenza in poultry. Very limited human-to-human transmission of the H5N1 strain was 
documented in healthcare workers and family members with contact. Until now, the disease has 
predominantly affected children and young adults (Kamps et al., 2006, World Health 
Organization, 2008). 
Table 1.1 shows the cumulative number of confirmed human cases of Avian Influenza A 
(H5N1) reported to World Health Organization (WHO) until 10 September 2008. Total number 
of cases includes number of deaths. WHO reports only laboratory-confirmed cases. All dates 
refer to onset of illness. 
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Table 1.1: Cumulative Number of Confirmed Human Cases of Avian Influenza A (H5Nl) 
Reported to WHO (World Health Organization, 2008) 
Country 2003 2004 2005 2006 2007 2008 Total 
Case Death Case Death Case Death Case Death Case Death Case Death Case Death 
Azerbaijan 0 0 0 0 0 0 8 5 0 0 0 0 8 5 
Bangladesh 0 0 0 0 0 0 0 0 0 0 1 0 1 0 
Cambodia 0 0 0 0 4 4 2 2 1 1 0 0 7 7 
China 1 1 0 0 8 5 13 8 5 3 3 3 30 20 
Djibouti 0 0 0 0 0 0 1 0 0 0 0 0 1 0 
Egypt 0 0 0 0 0 0 18 10 25 9 7 3 50 22 
Indonesia 0 0 0 0 20 13 55 45 42 37 20 17 137 112 
Iraq 0 0 0 0 0 0 3 2 0 0 0 0 3 2 
Lao 
People's 
0 0 0 0 0 0 0 0 2 2 0 0 2 2 
Democratic 
Republic 
Myanmar 0 0 0 0 0 0 0 0 1 0 0 0 1 0 
Nigeria 0 0 0 0 0 0 0 0 1 1 0 0 1 1 
Pakistan 0 0 0 0 0 0 0 0 3 1 0 0 3 1 
Thailand 0 0 17 12 5 2 3 3 0 0 0 0 25 17 
Turkey 0 0 0 0 0 0 12 4 0 0 0 0 12 4 
VietNam 3 3 29 20 61 19 0 0 8 5 5 5 106 52 
Total 4 4 46 32 98 43 115 79 88 59 36 28 387 245 
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1.11 Assembly PCR 
Advances in the area of chemical synthesis of DNA molecules have made it possible to 
synthesis and assemble genes for specific functions or optimization of functions and addition or 
deletion or specific features from a gene sequence. Several methods have been described 
previously for the synthesis and assembly of DNA sequences. These include a method for 
enzymatic ligation of oligonucleotides, Fokl method and a self-priming PCR that was developed 
in the early 1990s. Assembly PCR was introduced by Stemmer in 1995 and further improved in 
2002. Most recently, thermodynamically balance inside-out (TBIO) PCR-based gene synthesis 
method and PCR-based two-step DNA synthesis have been developed for longer genes 
(Stemmer eta/., 1995; Xiong eta/., 2004). 
Assembly PCR is based on DNA shuftling, which relies on the activity of DNA 
polymerase to build DNA fragment. It consists of four steps which include oligonucleotide 
design and synthesis, gene assembly, gene amplification and cloning (Rydzanicz eta/., 2005). 
1.12 Aim of this Study 
The ultimate aim of this study is to produce highly immunogenic/hydrophilic HA/NA 
synthetic gene. This immunogenic/hydrophilic HA/N A will be synthesized using assembly 
PCR. The synthetic gene that has been produced, will be transformed into E.coli (DH5a) 
competent cells and cloned into pCR®2.1-TOPO®vector. The recombinant E.coli (DH5a.) which 
contains our gene of interested will be extracted and send for sequencing. If the synthetic gene 
produced fulfills criteria that we want, it can be further used in production of vaccine for Avian 
Influenza caused by H5Nl. Figure 1.3 shows the flow of the study. 
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Figure 1.3 Flow chart of the study 
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Conformation of construct by DNA sequencing 
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